Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery
Recruiting
Phase 4
Interventional Study
Hemorrhage
Bariatric Surgery
Obesity, Morbid
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 140 (estimated)
- Sponsor
- Patel Hospital, Pakistan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if tranexamic acid (TXA) helps reduce bleeding during bariatric surgery, such as laparoscopic sleeve gastrectomy (LSG) and mini gastric bypass (MGB). It will also look at how safe TXA is for people undergoing these procedures. The main questions it aims to answer are:
Does TXA reduce the amount of blood loss during bariatric surgery? Are there any side …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients above 18 years of age AND
* Undergoing Laparoscopic Sleeve Gastrectomy and MGB
* Morbid obesity
Exclusion Criteria:
* Patients on anti-platelets/anti-coagulants
* Patients with inherited or acquired bleeding disorders
* Patients with any acute medical condition pred…
Contacts